The EMT phenotype driven by IL-6/STAT4/HIF-1α/SNAI1 axis promoted the growth and metastases of residue HCC cells and attenuated the anti-HCC effect of DOX, which resulted in the failure of TACE treatment. This evidence concerns the gene SNAI1 and hepatocellular carcinoma.